$IOVA
Given the preliminary data for lung from November & its same compound which is well tolerated, it looks like more than 50% that it gets approved.
That 7xes peak sales from current 1 billion
At 50% chance & 3x peak sales thats 12bn market cap, still a 4x and 20% are short